In CRC, CCND1 overexpression has yielded conflicting results, as some researchers demonstrated its role in promoting poor clinical outcomes, while others reported it as a good prognostic marker [117,118,119,120]. This evidence concerns the gene CCND1 and colorectal carcinoma.